Similarly, Zhang and colleagues found in a colon cancer cell line, knocking down ERCC1 protein expression increased the response to cells to CPT-11 in combination with ABT-888 as measured by γ-H2AX phosphorylation [26]. This evidence concerns the gene H2AX and malignant colon neoplasm.